Obesity Treating Neuromodulation System Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Obesity is a condition characterized by an excess of body fat that is generally described as 20% or more of one's ideal weight. Obesity is a health risk that prevents people from performing daily tasks. Excess weight is linked to a variety of diseases such as hypertension, stroke, diabetes, heart attack, osteoarthritis, and others. Obesity is defined by the WHO as having a body mass index of 30. Obesity is the fifth leading cause of death, according to the World Health Organization. It has become a major public health concern around the world as a result of a variety of factors like genetics and human behaviors. Neuromodulation has shown some potential for the treatment of obesity, and it is less invasive than surgical options such as gastric banding and gastric bypass. The appetite signal between the gut and the brain is manipulated by the obesity-treating neuromodulation system.
MARKET DYNAMICS
Factors driving the growth of the obesity treating neuromodulation system market are the growing prevalence of obese population., coupled with rising awareness among people regarding benefit of neuromodulation system over tradition treatment. However, the hesitation among people to get implant for obesity treatment and complications associated with the neuromodulation devices is expected to hamper the growth of the market. Moreover, increasing adoption of novel technology and advancement in the neuromodulation devices and rising product approval is anticipated to boost the market growth.
MARKET SCOPE
The "Obesity Treating Neuromodulation System Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of obesity treating neuromodulation system market with detailed market segmentation by product type and end user. The obesity treating neuromodulation system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in obesity treating neuromodulation system market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The obesity treating neuromodulation system market is segmented on the basis of product type and end user. Based on product type, the market is segmented as deep brain stimulator, spinal cord stimulator, vagus nerve stimulator, splanchnic nerve stimulator, autonomous nerve stimulator, and other. On the basis of end-user, the market is categorized as hospitals, clinics, and ambulatory surgical centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the obesity treating neuromodulation system market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The obesity treating neuromodulation system market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting obesity treating neuromodulation system market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the obesity treating neuromodulation system market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the obesity treating neuromodulation system market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The obesity treating neuromodulation system market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting obesity treating neuromodulation system market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the obesity treating neuromodulation system market in these regions.
MARKET PLAYERS
The report covers key developments in the obesity treating neuromodulation system market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from obesity treating neuromodulation system market are anticipated to have lucrative growth opportunities in the future with the rising demand for obesity treating neuromodulation system in the global market. Below mentioned is the list of few companies engaged in the obesity treating neuromodulation system market.
The report also includes the profiles of key players in obesity treating neuromodulation system market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- BioControl Medical
- Leptos Medical, Inc.
- EnteroMedics, Inc.
- Nevro Corp.
- Nuvectra.
- Abbott
- ReShape Lifesciences
- Medtronic plc.
- Cyberonics, Inc.
- St. Jude Medical, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Obesity Treating Neuromodulation System Market - By Product Type
1.3.2 Obesity Treating Neuromodulation System Market - By End user
1.3.3 Obesity Treating Neuromodulation System Market - By End user
1.3.4 Obesity Treating Neuromodulation System Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OBESITY TREATING NEUROMODULATION SYSTEM MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OBESITY TREATING NEUROMODULATION SYSTEM MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OBESITY TREATING NEUROMODULATION SYSTEM MARKET - GLOBAL MARKET ANALYSIS
6.1. OBESITY TREATING NEUROMODULATION SYSTEM - GLOBAL MARKET OVERVIEW
6.2. OBESITY TREATING NEUROMODULATION SYSTEM - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. OBESITY TREATING NEUROMODULATION SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DEEP BRAIN STIMULATOR
7.3.1. Overview
7.3.2. Deep Brain Stimulator Market Forecast and Analysis
7.4. SPINAL CORD STIMULATOR
7.4.1. Overview
7.4.2. Spinal Cord Stimulator Market Forecast and Analysis
7.5. VAGUS NERVE STIMULATOR
7.5.1. Overview
7.5.2. Vagus Nerve Stimulator Market Forecast and Analysis
7.6. SPLANCHNIC NERVE STIMULATOR
7.6.1. Overview
7.6.2. Splanchnic Nerve Stimulator Market Forecast and Analysis
7.7. AUTONOMOUS NERVE STIMULATOR
7.7.1. Overview
7.7.2. Autonomous Nerve Stimulator Market Forecast and Analysis
7.8. OTHER
7.8.1. Overview
7.8.2. Other Market Forecast and Analysis
8. OBESITY TREATING NEUROMODULATION SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTERS
8.5.1. Overview
8.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
9. OBESITY TREATING NEUROMODULATION SYSTEM MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. AMBULATORY SURGICAL CENTERS
9.5.1. Overview
9.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
10. OBESITY TREATING NEUROMODULATION SYSTEM MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Obesity Treating Neuromodulation System Market Overview
10.1.2 North America Obesity Treating Neuromodulation System Market Forecasts and Analysis
10.1.3 North America Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Product Type
10.1.4 North America Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.1.5 North America Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.1.6 North America Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Countries
10.1.6.1 United States Obesity Treating Neuromodulation System Market
10.1.6.1.1 United States Obesity Treating Neuromodulation System Market by Product Type
10.1.6.1.2 United States Obesity Treating Neuromodulation System Market by End user
10.1.6.1.3 United States Obesity Treating Neuromodulation System Market by End user
10.1.6.2 Canada Obesity Treating Neuromodulation System Market
10.1.6.2.1 Canada Obesity Treating Neuromodulation System Market by Product Type
10.1.6.2.2 Canada Obesity Treating Neuromodulation System Market by End user
10.1.6.2.3 Canada Obesity Treating Neuromodulation System Market by End user
10.1.6.3 Mexico Obesity Treating Neuromodulation System Market
10.1.6.3.1 Mexico Obesity Treating Neuromodulation System Market by Product Type
10.1.6.3.2 Mexico Obesity Treating Neuromodulation System Market by End user
10.1.6.3.3 Mexico Obesity Treating Neuromodulation System Market by End user
10.2. EUROPE
10.2.1 Europe Obesity Treating Neuromodulation System Market Overview
10.2.2 Europe Obesity Treating Neuromodulation System Market Forecasts and Analysis
10.2.3 Europe Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Product Type
10.2.4 Europe Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.2.5 Europe Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.2.6 Europe Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Obesity Treating Neuromodulation System Market
10.2.6.1.1 Germany Obesity Treating Neuromodulation System Market by Product Type
10.2.6.1.2 Germany Obesity Treating Neuromodulation System Market by End user
10.2.6.1.3 Germany Obesity Treating Neuromodulation System Market by End user
10.2.6.2 France Obesity Treating Neuromodulation System Market
10.2.6.2.1 France Obesity Treating Neuromodulation System Market by Product Type
10.2.6.2.2 France Obesity Treating Neuromodulation System Market by End user
10.2.6.2.3 France Obesity Treating Neuromodulation System Market by End user
10.2.6.3 Italy Obesity Treating Neuromodulation System Market
10.2.6.3.1 Italy Obesity Treating Neuromodulation System Market by Product Type
10.2.6.3.2 Italy Obesity Treating Neuromodulation System Market by End user
10.2.6.3.3 Italy Obesity Treating Neuromodulation System Market by End user
10.2.6.4 Spain Obesity Treating Neuromodulation System Market
10.2.6.4.1 Spain Obesity Treating Neuromodulation System Market by Product Type
10.2.6.4.2 Spain Obesity Treating Neuromodulation System Market by End user
10.2.6.4.3 Spain Obesity Treating Neuromodulation System Market by End user
10.2.6.5 United Kingdom Obesity Treating Neuromodulation System Market
10.2.6.5.1 United Kingdom Obesity Treating Neuromodulation System Market by Product Type
10.2.6.5.2 United Kingdom Obesity Treating Neuromodulation System Market by End user
10.2.6.5.3 United Kingdom Obesity Treating Neuromodulation System Market by End user
10.2.6.6 Rest of Europe Obesity Treating Neuromodulation System Market
10.2.6.6.1 Rest of Europe Obesity Treating Neuromodulation System Market by Product Type
10.2.6.6.2 Rest of Europe Obesity Treating Neuromodulation System Market by End user
10.2.6.6.3 Rest of Europe Obesity Treating Neuromodulation System Market by End user
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Obesity Treating Neuromodulation System Market Overview
10.3.2 Asia-Pacific Obesity Treating Neuromodulation System Market Forecasts and Analysis
10.3.3 Asia-Pacific Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.3.5 Asia-Pacific Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.3.6 Asia-Pacific Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Obesity Treating Neuromodulation System Market
10.3.6.1.1 Australia Obesity Treating Neuromodulation System Market by Product Type
10.3.6.1.2 Australia Obesity Treating Neuromodulation System Market by End user
10.3.6.1.3 Australia Obesity Treating Neuromodulation System Market by End user
10.3.6.2 China Obesity Treating Neuromodulation System Market
10.3.6.2.1 China Obesity Treating Neuromodulation System Market by Product Type
10.3.6.2.2 China Obesity Treating Neuromodulation System Market by End user
10.3.6.2.3 China Obesity Treating Neuromodulation System Market by End user
10.3.6.3 India Obesity Treating Neuromodulation System Market
10.3.6.3.1 India Obesity Treating Neuromodulation System Market by Product Type
10.3.6.3.2 India Obesity Treating Neuromodulation System Market by End user
10.3.6.3.3 India Obesity Treating Neuromodulation System Market by End user
10.3.6.4 Japan Obesity Treating Neuromodulation System Market
10.3.6.4.1 Japan Obesity Treating Neuromodulation System Market by Product Type
10.3.6.4.2 Japan Obesity Treating Neuromodulation System Market by End user
10.3.6.4.3 Japan Obesity Treating Neuromodulation System Market by End user
10.3.6.5 South Korea Obesity Treating Neuromodulation System Market
10.3.6.5.1 South Korea Obesity Treating Neuromodulation System Market by Product Type
10.3.6.5.2 South Korea Obesity Treating Neuromodulation System Market by End user
10.3.6.5.3 South Korea Obesity Treating Neuromodulation System Market by End user
10.3.6.6 Rest of Asia-Pacific Obesity Treating Neuromodulation System Market
10.3.6.6.1 Rest of Asia-Pacific Obesity Treating Neuromodulation System Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Obesity Treating Neuromodulation System Market by End user
10.3.6.6.3 Rest of Asia-Pacific Obesity Treating Neuromodulation System Market by End user
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Obesity Treating Neuromodulation System Market Overview
10.4.2 Middle East and Africa Obesity Treating Neuromodulation System Market Forecasts and Analysis
10.4.3 Middle East and Africa Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.4.5 Middle East and Africa Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.4.6 Middle East and Africa Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Obesity Treating Neuromodulation System Market
10.4.6.1.1 South Africa Obesity Treating Neuromodulation System Market by Product Type
10.4.6.1.2 South Africa Obesity Treating Neuromodulation System Market by End user
10.4.6.1.3 South Africa Obesity Treating Neuromodulation System Market by End user
10.4.6.2 Saudi Arabia Obesity Treating Neuromodulation System Market
10.4.6.2.1 Saudi Arabia Obesity Treating Neuromodulation System Market by Product Type
10.4.6.2.2 Saudi Arabia Obesity Treating Neuromodulation System Market by End user
10.4.6.2.3 Saudi Arabia Obesity Treating Neuromodulation System Market by End user
10.4.6.3 U.A.E Obesity Treating Neuromodulation System Market
10.4.6.3.1 U.A.E Obesity Treating Neuromodulation System Market by Product Type
10.4.6.3.2 U.A.E Obesity Treating Neuromodulation System Market by End user
10.4.6.3.3 U.A.E Obesity Treating Neuromodulation System Market by End user
10.4.6.4 Rest of Middle East and Africa Obesity Treating Neuromodulation System Market
10.4.6.4.1 Rest of Middle East and Africa Obesity Treating Neuromodulation System Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Obesity Treating Neuromodulation System Market by End user
10.4.6.4.3 Rest of Middle East and Africa Obesity Treating Neuromodulation System Market by End user
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Obesity Treating Neuromodulation System Market Overview
10.5.2 South and Central America Obesity Treating Neuromodulation System Market Forecasts and Analysis
10.5.3 South and Central America Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.5.5 South and Central America Obesity Treating Neuromodulation System Market Forecasts and Analysis - By End user
10.5.6 South and Central America Obesity Treating Neuromodulation System Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Obesity Treating Neuromodulation System Market
10.5.6.1.1 Brazil Obesity Treating Neuromodulation System Market by Product Type
10.5.6.1.2 Brazil Obesity Treating Neuromodulation System Market by End user
10.5.6.1.3 Brazil Obesity Treating Neuromodulation System Market by End user
10.5.6.2 Argentina Obesity Treating Neuromodulation System Market
10.5.6.2.1 Argentina Obesity Treating Neuromodulation System Market by Product Type
10.5.6.2.2 Argentina Obesity Treating Neuromodulation System Market by End user
10.5.6.2.3 Argentina Obesity Treating Neuromodulation System Market by End user
10.5.6.3 Rest of South and Central America Obesity Treating Neuromodulation System Market
10.5.6.3.1 Rest of South and Central America Obesity Treating Neuromodulation System Market by Product Type
10.5.6.3.2 Rest of South and Central America Obesity Treating Neuromodulation System Market by End user
10.5.6.3.3 Rest of South and Central America Obesity Treating Neuromodulation System Market by End user
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL OBESITY TREATING NEUROMODULATION SYSTEM MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. OBESITY TREATING NEUROMODULATION SYSTEM MARKET, KEY COMPANY PROFILES
13.1. BIOCONTROL MEDICAL
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. LEPTOS MEDICAL, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ENTEROMEDICS, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NEVRO CORP.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NUVECTRA.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ABBOTT
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. RESHAPE LIFESCIENCES
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MEDTRONIC PLC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CYBERONICS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ST. JUDE MEDICAL, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. BioControl Medical
2. Leptos Medical, Inc.
3. EnteroMedics, Inc.
4. Nevro Corp.
5. Nuvectra.
6. Abbott
7. ReShape Lifesciences
8. Medtronic plc.
9. Cyberonics, Inc.
10. St. Jude Medical, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For